Latest Leverage News

Intelligent Monitoring Group (IMG) is set to acquire Bluesky Holdco, owner of Tyco New Zealand and Red Wolf Security, in a deal expected to boost FY26 EBITDA by 28.3%. This move significantly strengthens IMG’s commercial security and fire services presence across Australasia.

Intelligent Monitoring Group has agreed to acquire Tyco NZ and Red Wolf for NZD 45 million, significantly boosting its New Zealand presence and FY26 earnings outlook.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

SenSen Networks reports robust Q2 FY26 revenue momentum, driven by five new city wins in North America, a surge in variable licence fees in Australia, and expanded fuel retail site deployments.

Marmota Limited’s maiden drilling program at the Greenewood gold discovery in South Australia reveals spectacular bonanza-grade gold assays over nearly 1km strike length, positioning the project as a standout in the Gawler Craton.

Tambourah Metals advances exploration at its Bryah Gold Project with new geophysical surveys, soil sampling, and heritage agreements, setting the stage for drilling in 2026.

Lunnon Metals reports significant high-grade gold assay results from the Lady Herial deposit, confirming promising mineralisation below and within the planned open pit. The company advances towards regulatory approvals and a final investment decision.

Neometals has signed a non-binding Letter of Intent with BML Ventures to jointly develop the Ironclad Gold Deposit, aiming for early production through a funded open-cut mining operation with profit sharing.

Boab Metals reveals a significant A$25 million capital cost reduction and a six-month faster construction timeline for its Sorby Hills Lead-Silver Project, bolstered by tender results and secured financing.

St Barbara Limited has completed a compelling restart study for its Touquoy gold project in Nova Scotia, outlining a low-capital, near-term operation with robust economics and a positive permitting outlook.

InhaleRx advances its clinical pipeline with a new oral treatment for resistant depression and plans a strategic rebrand to Nexalis Therapeutics, signaling a broader focus beyond inhaled therapies.

Stakk Limited reveals a striking 566% year-to-date growth in annual recurring revenue, driven by its pivot to a B2B embedded finance platform and strategic US market expansion. The company also secured a $15 million institutional placement, underpinning its ambitious growth plans.